McKesson Corporation

MCK

US58155Q1031

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2024-04-25 pm EDT			5-day change	1st Jan Change
539.9 ^USD	+0.84%		+4.07%	+16.62%

Apr. 24	McKesson Keeps Quarterly Dividend at $0.62 Per Share; Payable July 1 to Shareholders of Record on June 3	MT
Apr. 24	McKesson Corporation Declares Quarterly Dividend, Payable on June 3, 2024	CI

McKesson Corporation(NYSE:MCK) dropped from Russell Midcap Growth Index

June 24, 2022 at 12:00 am EDT

Latest news about McKesson Corporation

McKesson Keeps Quarterly Dividend at $0.62 Per Share; Payable July 1 to Shareholders of Record on June 3	Apr. 24	MT
McKesson Corporation Declares Quarterly Dividend, Payable on June 3, 2024	Apr. 24	CI
Mizuho Securities Raises Price Target on McKesson to $540 From $505, Neutral Rating Kept	Apr. 22	MT
Nephron Research Raises McKesson's Price Target to $600 From $530	Apr. 18	MT
Morgan Stanley Adjusts Price Target on McKesson to $548 From $522	Apr. 15	MT
Argus Raises Price Target on McKesson to $570 From $510, Keeps Buy Rating	Apr. 10	MT
Rite Aid reaches bankruptcy settlement with lenders, DOJ, McKesson	Mar. 26	RE
Mckesson Insider Sold Shares Worth $1,821,762, According to a Recent SEC Filing	Mar. 19	MT
What has UnitedHealth restored and what is next after major hack?	Mar. 14	RE
Transcript : McKesson Corporation Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 09:00 AM	Mar. 13
Rockwell Automation Hires New Chief Information Security Officer	Mar. 12	MT
Deutsche Bank Raises McKesson Price Target to $547 From $517, Maintains Buy Rating	Mar. 07	MT
UBS Adjusts McKesson Price Target to $620 From $575, Maintains Buy Rating	Mar. 06	MT
Leerink Partners Starts Coverage on McKesson With Outperform Rating, $600 Price Target	Feb. 26	MT
The latest transactions by star fund managers	Feb. 15
US FTC, DHHS Request Information on Shortages of Generic Drugs; McKesson Shares Ease	Feb. 14	MT
UBS Adjusts McKesson Price Target to $575 From $559, Maintains Buy Rating	Feb. 09	MT
Mizuho Adjusts Price Target on McKesson to $505 From $450, Keeps Neutral Rating	Feb. 09	MT
Citigroup Ups Price Target on McKesson to $575 From $530, Maintains Buy Rating	Feb. 08	MT
Global markets live: Kering, Publicis, Paypal, Mattel, Nvidia...	Feb. 08
Evercore ISI Adjusts Price Target on McKesson to $560 From $515, Maintains Outperform Rating	Feb. 08	MT
Baird Raises Price Target on McKesson to $567 From $519, Maintains Outperform Rating	Feb. 08	MT
McKesson raises annual profit forecast on strong demand for specialty medicines	Feb. 07	RE
McKesson Fiscal Q3 Adjusted EPS, Revenue Increase; Ups Adjusted EPS Outlook	Feb. 07	MT
Mckesson Corporation Provides Operating Profit Guidance for the Year 2024	Feb. 07	CI

McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows: - distribution of pharmaceutical products (87%); - distribution of medical and surgical products (4%); - other (1.6%): primarily technology services and software sales. The remaining net sales (7.4%) are from international activities.

Sector

Pharmaceuticals

Calendar

2024-05-07 - Q4 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for McKesson Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

539.9 USD

Average target price

559.5 USD

Spread / Average Target

+3.63%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
MCKESSON CORPORATION	+16.62%	70.95B
CARDINAL HEALTH, INC.	+2.99%	25.25B
SINOPHARM GROUP CO. LTD.	+5.13%	8.67B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+6.46%	8.16B
HUADONG MEDICINE CO., LTD	-21.01%	7.91B
H. LUNDBECK A/S	+0.73%	4.51B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.12%	4.31B
EBOS GROUP LIMITED	-0.14%	4.07B
GALENICA AG	-3.37%	3.84B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+21.70%	3.63B

Pharmaceuticals Wholesale